At the news
? NEUTRALIMPACT 2/10 144 filed Apr 13, 2026 at 16:44 ET
Daniel Bensen, an officer of Tyra Biosciences, filed a Form 144 to notify intent to sell up to 8,000 shares of common stock, valued at approximately $285,000, in two planned transactions on February 12 and March 12, 2026. This represents a routine, small-scale disposal of founder shares.
- Reporting person: Daniel Bensen, Officer
- Shares intended for sale: 8,000 shares (split across two planned sales)
- Total value of shares: $285,000 (average price ~$35.63/share)
- Shares are founder shares originally issued on August 28, 2018
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access